Led by Leslie Morrow, research shows how new compounds could target specific brain cell receptors to treat a wide variety of conditions, such as alcoholism, Alzheimer’s, depression, and posttraumatic stress.
Read MoreHigh Point biopharma VTVT sees positive results for treatment of mild Alzheimer’s, cuts losses.
Read More
Besides a cure, what do those afraid of Alzheimer’s disease need most? According to entrepreneur and philanthropist Bill Gates, a key need is a “reliable, affordable, and accessible” diagnostic test.
Read More
VTV Therapeutics Inc. saw its stock price fall by more than 65 percent in after-market trading Monday after it disclosed disappointing results from the clinical trial of an experimental Alzheimer’s medication.
Read MoreTd# Therapeutics, a company developing a drug to treat Alzheimer’s disease, has raised $6 million in a private equity offering
Read MoreTen years ago, University of North Carolina at Chapel Hill scientist Anne Taylor, Ph.D., then a bioengineering graduate student at the University of California at Irvine, wanted to make a contribution to neuroscience from an engineering standpoint. So she invented a device that her husband, attorney Brad Taylor, calls “an artificial brain on a chip.” That evolved into a company: XONA Microfluidics. XONA moved its two-person R&D operations to North Carolina when Anne Taylor accepted a position as assistant professor of bioengineering at UNC in 2010. Anne Taylor invented the device in the laboratory of Noo Li Jeon, Ph.D.,...
Read More
